Companies: 10,795·Total market cap: $144.5T
Oncolytics Biotech Inc.

Oncolytics Biotech Inc.

ONCYNASDAQHealthcare● Active
$0.86
+$0.02(+1.92%)
Market Cap$85919052
P/E Ratio—
52W High$1.51
52W Low$0.42
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Oncolytics Biotech Inc. (ONCY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001129928 · ONCY · NASDAQ · as of Jun 9, 2026

Filing snapshot

1,000+
Total Filings
3
Latest Form
2026-06-03
Most Recent
2001
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001129928 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-30
Fiscal Year End
Mar 30, 2026
Accession No.
0001129928-26-000020
Primary Document
oncy-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001129928 · Accession 0001129928-26-000020

Latest Key Filings

6-KQuarterly Report
6-K
2026-01-07
View 6-K on SEC
8-KCurrent Report
8-K
2026-06-02Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
3Initial Statement of Beneficial Ownership
3
2026-06-03
View
3Initial Statement of Beneficial Ownership
3
2026-06-03
View
8-KCurrent Report
8-K
2026-06-02
View
8-KCurrent Report
8-K
2026-06-01
View
8-KCurrent Report
8-K
2026-05-22
View
10-QQuarterly Report
10-Q
2026-05-14
View
8-KCurrent Report
8-K
2026-05-04
View
8-KCurrent Report
8-K
2026-04-27
View
F-10POSF-10POS
F-10POS
2026-04-08
View
F-10POSF-10POS
F-10POS
2026-04-08
View
F-10POSF-10POS
F-10POS
2026-04-08
View
F-10POSF-10POS
F-10POS
2026-04-08
View
F-10POSF-10POS
F-10POS
2026-04-08
View
F-10POSF-10POS
F-10POS
2026-04-08
View
F-10POSF-10POS
F-10POS
2026-04-08
View
Showing 1–15 of 974 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001129928  |  Exchange: NASDAQ · Healthcare

Oncolytics Biotech Inc. (NASDAQ: ONCY) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2001. As a Healthcare sector company with CIK 0001129928, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Oncolytics Biotech Inc.'s most comprehensive regulatory disclosure. The most recent Oncolytics Biotech Inc. 10-K was filed on 2026-03-30 for fiscal year ending 2026. Historical ONCY 10-K annual reports are available from 2007 through 2026.

Investors researching Oncolytics Biotech Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
IMMX SEC Filings →ZNTL SEC Filings →MGNX SEC Filings →WHWK SEC Filings →SRZN SEC Filings →COYA SEC Filings →CLNN SEC Filings →TIL SEC Filings →
→ ONCY Financials→ ONCY Earnings→ ONCY Insider Trades

Frequently Asked Questions

ONCY SEC Filings · 8 questions

Oncolytics Biotech Inc. (ONCY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Oncolytics Biotech Inc.'s CIK is 0001129928.

ONCY SEC filingsOncolytics Biotech Inc. SEC documentsfind ONCY 10-K